[1]
Patel, S. et al. 2016. Comparison of Induction Therapy Using Antithymocyte Globulin and Using Basiliximab for Live Donor Kidney Transplant Recipients: A Single Centre Prospective Cohort Study. Asian Journal of Pharmaceutical and Clinical Research. 9, 6 (Nov. 2016), 187–191. DOI:https://doi.org/10.22159/ajpcr.2016.v9i6.14099.